BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reaven GM. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab. 2003;88:2399-2403. [PMID: 12788834 DOI: 10.1210/jc.2003-030087] [Cited by in Crossref: 182] [Cited by in F6Publishing: 138] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Cai Z, Xiao M, Chang L, Yan L. Role of insulin resistance in Alzheimer’s disease. Metab Brain Dis 2015;30:839-51. [DOI: 10.1007/s11011-014-9631-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
2 Kidambi S, Kotchen JM, Krishnaswami S, Grim CE, Kotchen TA. Hypertension, Insulin Resistance, and Aldosterone: Sex-Specific Relationships. The Journal of Clinical Hypertension 2009;11:130-7. [DOI: 10.1111/j.1751-7176.2009.00084.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
3 Vasdev S, Gill V, Singal P. Role of Advanced Glycation End Products in Hypertension and Atherosclerosis: Therapeutic Implications. Cell Biochem Biophys 2007;49:48-63. [DOI: 10.1007/s12013-007-0039-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
4 El-Bassossy HM, Abo-Warda SM, Fahmy A. Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation. Am J Chin Med 2014;42:1153-67. [PMID: 25169908 DOI: 10.1142/S0192415X14500724] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
5 Ashfaq F, Goel PK, Sethi R, Khan MI, Ali W, Idris MZ. Lipoprotein (a) Levels in Relation to Severity of Coronary Artery Disease in North Indian Patients. Heart Views 2013;14:12-6. [PMID: 23580919 DOI: 10.4103/1995-705X.107114] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Di Nardo F, Boemi M, Burattini R. Assessment of hepatic insulin degradation, in normoglycemic hypertensive patients, by minimal modelling of standard intravenous glucose tolerance test data. Comput Methods Programs Biomed 2010;97:189-98. [PMID: 19767120 DOI: 10.1016/j.cmpb.2009.08.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
7 Mayer MA, Höcht C, Giani JF, Muñoz MC, Carranza A, Taira CA, Dominici FP, Puyó AM, Fernández BE. Central insulin-angiotensin II interaction in blood pressure regulation in fructose overloaded rats. Regul Pept 2013;185:37-43. [PMID: 23816464 DOI: 10.1016/j.regpep.2013.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Hwu CM, Hsiung CA, Wu KD, Lee WJ, Shih KC, Grove J, Chen YD, Rodriguez BL, Curb JD; SAPPHIRe Study Group. Diagnosis of insulin resistance in hypertensive patients by the metabolic syndrome: AHA vs. IDF definitions. Int J Clin Pract 2008;62:1441-6. [PMID: 18564200 DOI: 10.1111/j.1742-1241.2008.01818.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
9 Carmichael JD, Danoff A, Milani D, Roubenoff R, Lesser ML, Livote E, Reitz RE, Ferris S, Kleinberg DL. GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90. Clin Endocrinol (Oxf) 2006;65:169-77. [PMID: 16886956 DOI: 10.1111/j.1365-2265.2006.02569.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
10 Maki KC. Dietary factors in the prevention of diabetes mellitus and coronary artery disease associated with the metabolic syndrome. The American Journal of Cardiology 2004;93:12-7. [DOI: 10.1016/j.amjcard.2004.02.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
11 Kimokoti RW, Newby PK. Dietary Patterns, Smoking, and Cardiovascular Diseases: A Complex Association. Curr Nutr Rep 2013;2:113-25. [DOI: 10.1007/s13668-013-0043-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Di Nardo F, Burattini R, Cogo CE, Faelli E, Ruggeri P. Age-related analysis of insulin resistance, body weight and arterial pressure in the Zucker fatty rat. Exp Physiol 2009;94:162-8. [PMID: 18820002 DOI: 10.1113/expphysiol.2008.044529] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
13 Galgani JE, de Jonge L, Rood JC, Smith SR, Young AA, Ravussin E. Urinary C-peptide excretion: a novel alternate measure of insulin sensitivity in physiological conditions. Obesity (Silver Spring) 2010;18:1852-7. [PMID: 20360760 DOI: 10.1038/oby.2010.70] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
14 Dogru T, Sonmez A, Tasci I, Yilmaz MI, Erdem G, Erturk H, Bingol N, Kilic S, Ozgurtas T. Plasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertension. J Hum Hypertens 2007;21:173-5. [PMID: 17096008 DOI: 10.1038/sj.jhh.1002114] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
15 Esteghamati A, Khalilzadeh O, Abbasi M, Nakhjavani M, Novin L, Esteghamati AR. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects. Clin Exp Hypertens. 2008;30:297-307. [PMID: 18633753 DOI: 10.1080/10641960802269919] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
16 Clément K, Le Stunff C, Meirhaeghe A, Dechartres A, Ferrieres J, Basdevant A, Boitard C, Amouyel P, Bougnères P. In obese and non-obese adults, the cis-regulatory rs361072 promoter variant of PIK3CB is associated with insulin resistance not with type 2 diabetes. Mol Genet Metab 2009;96:129-32. [PMID: 19097921 DOI: 10.1016/j.ymgme.2008.11.160] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
17 Eid HMA, Lyberg T, Arnesen H, Seljeflot I. Insulin and adiponectin inhibit the TNFα-induced ADMA accumulation in human endothelial cells. Atherosclerosis 2007;194:e1-8. [DOI: 10.1016/j.atherosclerosis.2006.11.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
18 Muresanu DF, Sharma HS. Chronic Hypertension Aggravates Heat Stress-Induced Cognitive Dysfunction and Brain Pathology: An Experimental Study in the Rat, Using Growth Hormone Therapy for Possible Neuroprotection. Annals of the New York Academy of Sciences 2007;1122:1-22. [DOI: 10.1196/annals.1403.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
19 Grundy SM. Metabolic Syndrome. In: Bonora E, Defronzo RA, editors. Diabetes Complications, Comorbidities and Related Disorders. Cham: Springer International Publishing; 2020. pp. 71-107. [DOI: 10.1007/978-3-030-36694-0_3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
20 Ashfaq F, Goel PK, Moorthy N, Sethi R, Khan MI, Idris MZ. Lipoprotein(a) and SYNTAX Score Association with Severity of Coronary Artery Atherosclerosis in North India. Sultan Qaboos Univ Med J 2012;12:465-72. [PMID: 23275843 DOI: 10.12816/0003172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
21 Jordan JE, Simandle SA, Tulbert CD, Busija DW, Miller AW. Fructose-fed rats are protected against ischemia/reperfusion injury. J Pharmacol Exp Ther 2003;307:1007-11. [PMID: 14534360 DOI: 10.1124/jpet.103.055970] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
22 Jia EZ, Yang ZJ, Chen SW, Qi GY, You CF, Ma JF, Zhang JX, Wang ZZ, Qian WC, Wang HY, Ma WZ. Level of proinsulin in association with cardiovascular risk factors and sleep snoring. World J Gastroenterol 2005;11:5047-52. [PMID: 16124064 DOI: 10.3748/wjg.v11.i32.5047] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
23 Mendez CE, Walker RJ, Eiler CR, Mishriky BM, Egede LE. Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality. Postgrad Med 2019;131:376-82. [PMID: 31311382 DOI: 10.1080/00325481.2019.1643635] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Landsberg L. The Sympatho-Adrenal System in the Metabolic Syndrome. In: Hansen BC, Bray GA, editors. The Metabolic Syndrome. Totowa: Humana Press; 2008. pp. 85-104. [DOI: 10.1007/978-1-60327-116-5_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Banerji MA, Chaiken RL. Insulin Resistance and the Metabolic Syndrome. In: Poretsky L, editor. Principles of Diabetes Mellitus. Boston: Springer US; 2010. pp. 531-55. [DOI: 10.1007/978-0-387-09841-8_34] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Grewal S, Fosam A, Chalk L, Deven A, Suzuki M, Correa RR, Blau JE, Demidowich AP, Stratakis CA, Muniyappa R. Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism. Endocrine 2021;72:96-103. [PMID: 33462741 DOI: 10.1007/s12020-020-02576-y] [Reference Citation Analysis]
27 Ward NC, Hodgson JM, Puddey IB, Beilin LJ, Croft KD. 20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans. Diabetes Res Clin Pract 2006;74:197-200. [PMID: 16713008 DOI: 10.1016/j.diabres.2006.04.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
28 Rao MN, Chau A, Madden E, Inslicht S, Talbot L, Richards A, O'Donovan A, Ruoff L, Grunfeld C, Neylan TC. Hyperinsulinemic response to oral glucose challenge in individuals with posttraumatic stress disorder. Psychoneuroendocrinology 2014;49:171-81. [PMID: 25108160 DOI: 10.1016/j.psyneuen.2014.07.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
29 Tomé MA, Botana MA, Cadarso-Suárez C, Rego-Iraeta A, Fernández-Mariño A, Mato JA, Solache I, Perez-Fernandez R. Prevalence of metabolic syndrome in Galicia (NW Spain) on four alternative definitions and association with insulin resistance. J Endocrinol Invest 2009;32:505-11. [PMID: 19465797 DOI: 10.1007/BF03346497] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
30 Rhodes ET, Goran MI, Lieu TA, Lustig RH, Prosser LA, Songer TJ, Weigensberg MJ, Weinstock RS, Gonzalez T, Rawluk K, Zoghbi RM, Ludwig DS, Laffel LM. Health-related quality of life in adolescents with or at risk for type 2 diabetes mellitus. J Pediatr 2012;160:911-7. [PMID: 22217471 DOI: 10.1016/j.jpeds.2011.11.026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
31 Kudo M, Sugawara A, Uruno A, Takeuchi K, Ito S. Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/ enhancer-binding protein delta during the early stage of adipocyte differentiation. Endocrinology 2004;145:4948-56. [PMID: 15284209 DOI: 10.1210/en.2004-0180] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
32 Katakam PV, Jordan JE, Snipes JA, Tulbert CD, Miller AW, Busija DW. Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 2007;292:R920-6. [PMID: 17008456 DOI: 10.1152/ajpregu.00520.2006] [Cited by in Crossref: 77] [Cited by in F6Publishing: 85] [Article Influence: 5.1] [Reference Citation Analysis]
33 Catena C, Bernardi S, Sabato N, Grillo A, Ermani M, Sechi LA, Fabris B, Carretta R, Fallo F. Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension. Nutr Metab Cardiovasc Dis. 2013;23:389-393. [PMID: 22796347 DOI: 10.1016/j.numecd.2012.05.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
34 Lee CJ, Lim N, Kim H, Ihm S, Lee H, Park HY, Park S. Impaired Fasting Glucose and Impaired Glucose Tolerance Do Not Predict Hypertension: A Community Cohort Study. American Journal of Hypertension 2015;28:493-500. [DOI: 10.1093/ajh/hpu186] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
35 Jung CH, Jung SH, Lee B, Rosenberg M, Reaven GM, Kim SH. Relationship among age, insulin resistance, and blood pressure. J Am Soc Hypertens 2017;11:359-365.e2. [PMID: 28558951 DOI: 10.1016/j.jash.2017.04.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
36 Girman CJ, Dekker JM, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ. An exploratory analysis of criteria for the metabolic syndrome and its prediction of long-term cardiovascular outcomes: the Hoorn study. Am J Epidemiol 2005;162:438-47. [PMID: 16076828 DOI: 10.1093/aje/kwi229] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
37 Khan AM, Cheng S, Magnusson M, Larson MG, Newton-Cheh C, McCabe EL, Coviello AD, Florez JC, Fox CS, Levy D. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab. 2011;96:3242-3249. [PMID: 21849523 DOI: 10.1210/jc.2011-1182] [Cited by in Crossref: 106] [Cited by in F6Publishing: 95] [Article Influence: 10.6] [Reference Citation Analysis]
38 Edel AL, Aliani M, Pierce GN. Stability of bioactives in flaxseed and flaxseed-fortified foods. Food Research International 2015;77:140-55. [DOI: 10.1016/j.foodres.2015.07.035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Yoon S, Assimes TL, Quertermous T, Hsiao CF, Chuang LM, Hwu CM, Rajaratnam B, Olshen RA. Insulin resistance: regression and clustering. PLoS One 2014;9:e94129. [PMID: 24887437 DOI: 10.1371/journal.pone.0094129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Barale C, Russo I. Influence of Cardiometabolic Risk Factors on Platelet Function. Int J Mol Sci 2020;21:E623. [PMID: 31963572 DOI: 10.3390/ijms21020623] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 21.0] [Reference Citation Analysis]
41 Maki KC, Rains TM, Kaden VN, Raneri KR, Davidson MH. Effects of a reduced-glycemic-load diet on body weight, body composition, and cardiovascular disease risk markers in overweight and obese adults. Am J Clin Nutr 2007;85:724-34. [PMID: 17344493 DOI: 10.1093/ajcn/85.3.724] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
42 Pinkston MM, Poston WSC, Reeves RS, Haddock CK, Taylor JE, Foreyt JP. Does metabolic syndrome mitigate weight loss in overweight Mexican American women treated for 1-year with orlistat and lifestyle modification? Eat Weight Disord 2006;11:e35-41. [DOI: 10.1007/bf03327751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Rizos CV. Manidipine: A different dihydropyridine. WJH 2011;1:3. [DOI: 10.5494/wjh.v1.i1.3] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
44 Fedoseeva LA, Klimov LO, Ershov NI, Alexandrovich YV, Efimov VM, Markel AL, Redina OE. Molecular determinants of the adrenal gland functioning related to stress-sensitive hypertension in ISIAH rats. BMC Genomics 2016;17:989. [PMID: 28105924 DOI: 10.1186/s12864-016-3354-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
45 Burattini R, Di Nardo F, Casagrande F, Boemi M, Morosini P. Insulin action and secretion in hypertension in the absence of metabolic syndrome: model-based assessment from oral glucose tolerance test. Metabolism 2009;58:80-92. [PMID: 19059535 DOI: 10.1016/j.metabol.2008.08.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
46 Abuissa H, O'Keefe J Jr. The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection. Diabetes Obes Metab 2008;10:1157-66. [PMID: 18494810 DOI: 10.1111/j.1463-1326.2008.00898.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
47 Fenton C, Keating GM, Lyseng-Williamson KA. Moxonidine: a review of its use in essential hypertension. Drugs 2006;66:477-96. [PMID: 16597164 DOI: 10.2165/00003495-200666040-00006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
48 . Guidelines on the management of arterial hypertension and related comorbidities in Latin America. Journal of Hypertension 2017;35:1529-45. [DOI: 10.1097/hjh.0000000000001418] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 7.8] [Reference Citation Analysis]
49 López-Jaramillo P, Sánchez RA, Diaz M, Cobos L, Bryce A, Parra Carrillo JZ, Lizcano F, Lanas F, Sinay I, Sierra ID. Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome. J Hypertens. 2013;31:223-238. [PMID: 23282894 DOI: 10.1097/hjh.0b013e32835c5444] [Cited by in Crossref: 46] [Cited by in F6Publishing: 8] [Article Influence: 5.8] [Reference Citation Analysis]
50 Tamsma J, Jazet I, Beishuizen E, Fogteloo A, Meinders A, Huisman M. The metabolic syndrome: A vascular perspective. European Journal of Internal Medicine 2005;16:314-20. [DOI: 10.1016/j.ejim.2005.01.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
51 Jia EZ, Yang ZJ, Chen SW, Qi GY, You CF, Ma JF, Zhang JX, Wang ZZ, Qian WC, Li XL, Wang HY, Ma WZ. Significant association of insulin and proinsulin with clustering of cardiovascular risk factors. World J Gastroenterol 2005;11:149-53. [PMID: 15609415 DOI: 10.3748/wjg.v11.i1.149] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Roth J, Qiang X, Marbán SL, Redelt H, Lowell BC. The Obesity Pandemic: Where Have We Been and Where Are We Going? Obesity Research 2004;12:88S-101S. [DOI: 10.1038/oby.2004.273] [Cited by in Crossref: 152] [Cited by in F6Publishing: 118] [Article Influence: 16.9] [Reference Citation Analysis]
53 Anfossi G, Russo I, Doronzo G, Trovati M. Contribution of insulin resistance to vascular dysfunction. Archives of Physiology and Biochemistry 2009;115:199-217. [DOI: 10.1080/13813450903136791] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
54 Noakes TD. Hiding unhealthy heart outcomes in a low-fat diet trial: the Women's Health Initiative Randomized Controlled Dietary Modification Trial finds that postmenopausal women with established coronary heart disease were at increased risk of an adverse outcome if they consumed a low-fat 'heart-healthy' diet. Open Heart 2021;8:e001680. [PMID: 34290045 DOI: 10.1136/openhrt-2021-001680] [Reference Citation Analysis]
55 Dziwura J, Bińczak-Kuleta A, Miazgowski T, Ziemak J, Widecka K. The associations between G972R polymorphism of the IRS-1 gene, insulin resistance, salt sensitivity and non-dipper hypertension. Hypertens Res 2011;34:1082-6. [PMID: 21677657 DOI: 10.1038/hr.2011.80] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
56 Ruderman NB, Shulman GI. Metabolic Syndrome. Endocrinology: Adult and Pediatric. Elsevier; 2016. pp. 752-769.e7. [DOI: 10.1016/b978-0-323-18907-1.00043-3] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
57 Eid HMA, Reims H, Arnesen H, Kjeldsen SE, Lyberg T, Seljeflot I. Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia. Metabolism 2007;56:464-9. [DOI: 10.1016/j.metabol.2006.11.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
58 Fuster DG, Bobulescu IA, Zhang J, Wade J, Moe OW. Characterization of the regulation of renal Na+/H+ exchanger NHE3 by insulin. Am J Physiol Renal Physiol 2007;292:F577-85. [PMID: 17018843 DOI: 10.1152/ajprenal.00240.2006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
59 Sasaki N, Ozono R, Higashi Y, Maeda R, Kihara Y. Association of Insulin Resistance, Plasma Glucose Level, and Serum Insulin Level With Hypertension in a Population With Different Stages of Impaired Glucose Metabolism. J Am Heart Assoc 2020;9:e015546. [PMID: 32200720 DOI: 10.1161/JAHA.119.015546] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
60 Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus--a review. Diabetes Technol Ther. 2006;8:677-687. [PMID: 17109600 DOI: 10.1089/dia.2006.8.677] [Cited by in Crossref: 111] [Cited by in F6Publishing: 76] [Article Influence: 7.9] [Reference Citation Analysis]
61 Fischer E, Adolf C, Pallauf A, Then C, Bidlingmaier M, Beuschlein F, Seissler J, Reincke M. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. J Clin Endocrinol Metab 2013;98:2513-20. [PMID: 23539730 DOI: 10.1210/jc.2012-3934] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
62 Salazar MR, Carbajal HA, Espeche WG, Balbín E, Aizpurúa M, Marillet AG, Reaven GM. Do differences in waist circumference modify the relationships among body mass index, insulin resistance, and related cardiometabolic risk factors in apparently healthy women? J Am Coll Nutr 2014;33:32-8. [PMID: 24533606 DOI: 10.1080/07315724.2014.869982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
63 Prakash P, Khanna V, Singh V, Jyoti A, Jain M, Keshari RS, Barthwal MK, Dikshit M. Atorvastatin Protects against Ischemia-Reperfusion Injury in Fructose-Induced Insulin Resistant Rats. Cardiovasc Drugs Ther 2011;25:285-97. [DOI: 10.1007/s10557-011-6312-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
64 Ozdoğan S, Kaman D, Simşek BÇ. Effects of coenzyme Q10 and α-lipoic acid supplementation in fructose fed rats. J Clin Biochem Nutr 2012;50:145-51. [PMID: 22448096 DOI: 10.3164/jcbn.11-47] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
65 Portilla J. [Patient-related cardiovascular risk factors in the HIV-infected population]. Enferm Infecc Microbiol Clin 2009;27 Suppl 1:10-6. [PMID: 20172410 DOI: 10.1016/S0213-005X(09)73440-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Karagiannis A, Mikhailidis DP, Athyros VG, Kakafika AI, Tziomalos K, Liberopoulos EN, Florentin M, Elisaf M. The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal? Expert Opinion on Therapeutic Targets 2007;11:191-205. [DOI: 10.1517/14728222.11.2.191] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
67 Penas-Steinhardt A, Tellechea ML, Gomez-Rosso L, Brites F, Frechtel GD, Poskus E. Association of common variants in JAK2 gene with reduced risk of metabolic syndrome and related disorders. BMC Med Genet 2011;12:166. [PMID: 22185674 DOI: 10.1186/1471-2350-12-166] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
68 Pang X, Zhao J, Zhang W, Zhuang X, Wang J, Xu R, Xu Z, Qu W. Antihypertensive effect of total flavones extracted from seed residues of Hippophae rhamnoides L. in sucrose-fed rats. Journal of Ethnopharmacology 2008;117:325-31. [DOI: 10.1016/j.jep.2008.02.002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
69 Pitsavos C, Panagiotakos DB, Tzima N, Lentzas Y, Chrysohoou C, Das UN, Stefanadis C. Diet, Exercise, and C-Reactive Protein Levels in People With Abdominal Obesity: The ATTICA Epidemiological Study. Angiology 2007;58:225-33. [DOI: 10.1177/0003319707300014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 6.4] [Reference Citation Analysis]
70 Rhodes ET, Prosser LA, Lieu TA, Songer TJ, Ludwig DS, Laffel LM. Preferences for type 2 diabetes health states among adolescents with or at risk of type 2 diabetes mellitus. Pediatr Diabetes 2011;12:724-32. [PMID: 21489091 DOI: 10.1111/j.1399-5448.2011.00772.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
71 Bremer AA, Stanhope KL, Graham JL, Cummings BP, Wang W, Saville BR, Havel PJ. Fructose-fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes. Clin Transl Sci 2011;4:243-52. [PMID: 21884510 DOI: 10.1111/j.1752-8062.2011.00298.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 80] [Article Influence: 9.3] [Reference Citation Analysis]
72 Hwu CM, Liou TL, Hsiao LC, Lin MW. Prehypertension is associated with insulin resistance. QJM 2009;102:705-11. [PMID: 19666708 DOI: 10.1093/qjmed/hcp107] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
73 Innes KE, Selfe TK, Taylor AG. Menopause, the metabolic syndrome, and mind-body therapies. Menopause 2008;15:1005-13. [PMID: 18779682 DOI: 10.1097/01.gme.0b013e318166904e] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
74 Matayoshi T, Kamide K, Takiuchi S, Horio T, Yoshihara F, Nakamura S, Nakahama H, Kawano Y. Relationship between Insulin Resistance and the Renin-Angiotensin System: Analysis for Patients with Essential and Renovascular Hypertension. Clinical and Experimental Hypertension 2009;29:479-87. [DOI: 10.1080/10641960701616186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
75 Sorriento D, Rusciano MR, Visco V, Fiordelisi A, Cerasuolo FA, Poggio P, Ciccarelli M, Iaccarino G. The Metabolic Role of GRK2 in Insulin Resistance and Associated Conditions. Cells 2021;10:167. [PMID: 33467677 DOI: 10.3390/cells10010167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Albert BB, de Bock M, Derraik JG, Brennan CM, Biggs JB, Hofman PL, Cutfield WS. Non-Dipping and Cardiometabolic Profile: A Study on Normotensive Overweight Middle-Aged Men. Heart, Lung and Circulation 2016;25:1218-25. [DOI: 10.1016/j.hlc.2016.04.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
77 Nazare J, Balkau B, Borel A. The Metabolic Syndrome. In: Reusch, Md JEB, Regensteiner, Phd, Ma, Ba JG, Stewart, Ed.d., Faha, Maacvpr, Facs KJ, Veves, Md, Dsc A, editors. Diabetes and Exercise. Cham: Springer International Publishing; 2018. pp. 31-45. [DOI: 10.1007/978-3-319-61013-9_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Shimizu H, Mori M. The brain–adipose axis: A review of involvement of molecules. Nutritional Neuroscience 2013;8:7-20. [DOI: 10.1080/10284150500047245] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
79 Blaha MJ, Bansal S, Rouf R, Golden SH, Blumenthal RS, Defilippis AP. A practical "ABCDE" approach to the metabolic syndrome. Mayo Clin Proc 2008;83:932-41. [PMID: 18674478 DOI: 10.4065/83.8.932] [Cited by in Crossref: 11] [Cited by in F6Publishing: 24] [Article Influence: 0.8] [Reference Citation Analysis]
80 Abdul-Ghani MA, Jayyousi A, DeFronzo RA, Asaad N, Al-Suwaidi J. Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications. Curr Vasc Pharmacol 2019;17:153-63. [PMID: 29032755 DOI: 10.2174/1570161115666171010115119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
81 Burattini R, Morettini M, Di Nardo F, Boemi M. Dynamics of insulin action in hypertension: assessment from minimal model interpretation of intravenous glucose tolerance test data. Med Biol Eng Comput 2011;49:831-41. [PMID: 21448693 DOI: 10.1007/s11517-011-0760-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
82 López-Jaramillo P, Sánchez RA, Diaz M, Cobos L, Bryce A, Parra-Carrillo JZ, Lizcano F, Lanas F, Sinay I, Sierra ID, Peñaherrera E, Bendersky M, Schmid H, Botero R, Urina M, Lara J, Foss MC, Márquez G, Harrap S, Ramírez AJ, Zanchetti A; Grupo de Especialistas da América Latina. [Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome]. Arq Bras Endocrinol Metabol 2014;58:205-25. [PMID: 24863082 DOI: 10.1590/0004-2730000003019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
83 Abdulla MH, Sattar MA, Johns EJ. The Relation between Fructose-Induced Metabolic Syndrome and Altered Renal Haemodynamic and Excretory Function in the Rat. Int J Nephrol 2011;2011:934659. [PMID: 21785727 DOI: 10.4061/2011/934659] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
84 Reaven GM. Compensatory Hyperinsulinemia and the Development of an Atherogenic Lipoprotein Profile: The Price Paid to Maintain Glucose Homeostasis in Insulin-Resistant Individuals. Endocrinology and Metabolism Clinics of North America 2005;34:49-62. [DOI: 10.1016/j.ecl.2004.12.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
85 Vasdev S, Gill V, Singal PK. Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms. Vasc Health Risk Manag 2006;2:263-76. [PMID: 17326332 DOI: 10.2147/vhrm.2006.2.3.263] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
86 Krug AW, Ehrhart-bornstein M. Aldosterone and Metabolic Syndrome: Is Increased Aldosterone in Metabolic Syndrome Patients an Additional Risk Factor? Hypertension 2008;51:1252-8. [DOI: 10.1161/hypertensionaha.107.109439] [Cited by in Crossref: 68] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
87 Sinaiko AR, Steinberger J, Moran A, Hong CP, Prineas RJ, Jacobs DR Jr. Influence of insulin resistance and body mass index at age 13 on systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol at age 19. Hypertension 2006;48:730-6. [PMID: 16923995 DOI: 10.1161/01.HYP.0000237863.24000.50] [Cited by in Crossref: 67] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
88 Tota-maharaj R, Defilippis AP, Blumenthal RS, Blaha MJ. A practical approach to the metabolic syndrome: review of current concepts and management. Current Opinion in Cardiology 2010;25:502-12. [DOI: 10.1097/hco.0b013e32833cd474] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
89 Korandji C, Zeller M, Guilland J, Collin B, Lauzier B, Sicard P, Duvillard L, Goirand F, Moreau D, Cottin Y, Rochette L, Vergely C. Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: A model related to metabolic syndrome. Atherosclerosis 2011;214:310-5. [DOI: 10.1016/j.atherosclerosis.2010.11.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
90 Meysamie A, Ghalehtaki R, Ghodsi S, Mohebi M, Ghalehtaki S, Salarvand F, Hosseini Z, Sadre-Bafghi SA. Is there an independent association between metabolic syndrome and smoking in Iranian adults? Results of a large multicenter national survey. Caspian J Intern Med 2021;12:327-35. [PMID: 34221284 DOI: 10.22088/cjim.12.3.327] [Reference Citation Analysis]
91 Manabe S, Okura T, Fukuoka T, Higaki J. Antioxidative effects of azelnidipine on mesangial cell proliferation induced by highly concentrated insulin. European Journal of Pharmacology 2007;567:252-7. [DOI: 10.1016/j.ejphar.2007.02.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
92 Yamada M, Satoh T, Mori M. Mice lacking the thyrotropin-releasing hormone gene: what do they tell us? Thyroid 2003;13:1111-21. [PMID: 14751031 DOI: 10.1089/10507250360731505] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
93 Natali A, Ferrannini E. Hypertension, insulin resistance, and the metabolic syndrome. Endocrinol Metab Clin North Am 2004;33:417-29. [PMID: 15158527 DOI: 10.1016/j.ecl.2004.03.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
94 Rochette L, Lorin J, Zeller M, Guilland J, Lorgis L, Cottin Y, Vergely C. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets? Pharmacology & Therapeutics 2013;140:239-57. [DOI: 10.1016/j.pharmthera.2013.07.004] [Cited by in Crossref: 214] [Cited by in F6Publishing: 181] [Article Influence: 26.8] [Reference Citation Analysis]
95 Blaha MJ, Bansal S, Rouf R, Golden SH, Blumenthal RS, Defilippis AP. A Practical “ABCDE” Approach to the Metabolic Syndrome. Mayo Clinic Proceedings 2008;83:932-43. [DOI: 10.1016/s0025-6196(11)60770-2] [Cited by in Crossref: 57] [Article Influence: 4.4] [Reference Citation Analysis]
96 Qureshi K, Abrams GA. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome. Clin Obes 2016;6:117-23. [PMID: 26856683 DOI: 10.1111/cob.12132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
97 Cannizzo B, Luján A, Estrella N, Lembo C, Cruzado M, Castro C. Insulin resistance promotes early atherosclerosis via increased proinflammatory proteins and oxidative stress in fructose-fed ApoE-KO mice. Exp Diabetes Res 2012;2012:941304. [PMID: 22474431 DOI: 10.1155/2012/941304] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
98 Noakes TD. So What Comes First: The Obesity or the Insulin Resistance? And Which Is More Important? Clin Chem 2018;64:7-9. [PMID: 29295832 DOI: 10.1373/clinchem.2017.282962] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
99 Dillon EL, Janghorbani M, Angel JA, Casperson SL, Grady JJ, Urban RJ, Volpi E, Sheffield-Moore M. Novel noninvasive breath test method for screening individuals at risk for diabetes. Diabetes Care 2009;32:430-5. [PMID: 19074994 DOI: 10.2337/dc08-1578] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
100 Chu JW, Abbasi F, Lamendola C, Mclaughlin T, Reaven GM, Tsao PS. Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects. Diabetes and Vascular Disease Research 2005;2:37-41. [DOI: 10.3132/dvdr.2005.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
101 Sivitz WI. Understanding insulin resistance. What are the clinical implications? Postgrad Med 2004;116:41-8. [PMID: 15274287 DOI: 10.3810/pgm.2004.07.1550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
102 Ware WR. Psychological stress, insulin resistance, inflammation and the assessment of heart disease risk. Time for a paradigm shift? Med Hypotheses 2008;71:45-52. [PMID: 18406066 DOI: 10.1016/j.mehy.2008.02.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
103 Hawkins JS, Lo JY, Casey BM, Mcintire DD, Leveno KJ. Diet-treated gestational diabetes mellitus: comparison of early vs routine diagnosis. American Journal of Obstetrics and Gynecology 2008;198:287.e1-6. [DOI: 10.1016/j.ajog.2007.11.049] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
104 Moreira MC, Pinto IS, Mourão AA, Fajemiroye JO, Colombari E, Reis ÂA, Freiria-Oliveira AH, Ferreira-Neto ML, Pedrino GR. Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome? Front Physiol 2015;6:234. [PMID: 26379553 DOI: 10.3389/fphys.2015.00234] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
105 Oliveira EP, Lima Md, Souza ML. [Metabolic syndrome, its phenotypes, and insulin resistance by HOMA-IR]. Arq Bras Endocrinol Metabol 2007;51:1506-15. [PMID: 18209894 DOI: 10.1590/s0004-27302007000900014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
106 Singh S, Dhingra S, Ramdath DD, Vasdev S, Gill V, Singal PK. Risk Factors Preceding Type 2 Diabetes and Cardiomyopathy. J of Cardiovasc Trans Res 2010;3:580-96. [DOI: 10.1007/s12265-010-9197-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
107 Samad MB, Hasan MN, Banarjee S, Rahman M, Raihan S, Banti FL, Sayfe SS, Hasan SN, Akhter F, Kabir AU, Hannan J. PEG modification of Amorfrutin B from Amorpha fructicosa increases gastric absorption, circulation half-life and glucose uptake by T3T-L1 adipocytes. Biomedicine & Pharmacotherapy 2017;95:513-9. [DOI: 10.1016/j.biopha.2017.08.113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, Acikel C, Oguz Y, Yavuz I, Vural A. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Nephrology 2007;12:147-53. [DOI: 10.1111/j.1440-1797.2007.00764.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
109 Maki KC. Fibrates for treatment of the metabolic syndrome. Curr Atheroscler Rep 2004;6:45-51. [DOI: 10.1007/s11883-004-0115-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
110 Chen CY, Hwu CM, Lin MW, Tsai CH, Yeh HI. High triglyceride level is associated with severe coronary artery disease in hypertensive subjects. Scand Cardiovasc J. 2008;42:146-152. [PMID: 18365898 DOI: 10.1080/14017430701840325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
111 Reaven GM. Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences. J Clin Hypertens (Greenwich) 2011;13:238-43. [PMID: 21466618 DOI: 10.1111/j.1751-7176.2011.00439.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 54] [Article Influence: 7.2] [Reference Citation Analysis]
112 Hwu C. Measurements of insulin resistance in hypertension: where are we now? J Hum Hypertens 2007;21:693-6. [DOI: 10.1038/sj.jhh.1002202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
113 Nalini D, Karthick R, Shirin V, Manohar G, Malathi R. “Role of the adipocyte hormone leptin in cardiovascular diseases - a study from Chennai based Population”. Thromb J. 2015;13:12. [PMID: 25762868 DOI: 10.1186/s12959-015-0042-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
114 Barrette PO, Schwertani AG. A closer look at the role of urotensin II in the metabolic syndrome. Front Endocrinol (Lausanne) 2012;3:165. [PMID: 23293629 DOI: 10.3389/fendo.2012.00165] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
115 Sinaiko AR, Caprio S. Insulin resistance. J Pediatr 2012;161:11-5. [PMID: 22336575 DOI: 10.1016/j.jpeds.2012.01.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
116 Fallo F, Dalla Pozza A, Sonino N, Lupia M, Tona F, Federspil G, Ermani M, Catena C, Soardo G, Di Piazza L. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutr Metab Cardiovasc Dis. 2009;19:646-653. [PMID: 19278843 DOI: 10.1016/j.numecd.2008.12.007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 5.6] [Reference Citation Analysis]
117 Sjöholm A, Nyström T. Endothelial inflammation in insulin resistance. Lancet 2005;365:610-2. [PMID: 15708106 DOI: 10.1016/S0140-6736(05)17912-4] [Cited by in Crossref: 117] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
118 Qureshi K, Clements RH, Saeed F, Abrams GA. Comparative evaluation of whole body and hepatic insulin resistance using indices from oral glucose tolerance test in morbidly obese subjects with nonalcoholic Fatty liver disease. J Obes 2010;2010:741521. [PMID: 20798875 DOI: 10.1155/2010/741521] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
119 Mallat A, Lotersztajn S. Cigarette smoke exposure: A novel cofactor of NAFLD progression? Journal of Hepatology 2009;51:430-2. [DOI: 10.1016/j.jhep.2009.05.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
120 Rizvi AA. Hypertension, obesity, and inflammation: the complex designs of a deadly trio. Metab Syndr Relat Disord 2010;8:287-94. [PMID: 20367224 DOI: 10.1089/met.2009.0116] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
121 Faure MJ, Rossini E, Ribuot C, Faure P. Fructose-Fed Rat Hearts are Protected Against Ischemia-Reperfusion Injury. Exp Biol Med (Maywood) 2006;231:456-62. [DOI: 10.1177/153537020623100411] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
122 Hamerman D. Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. QJM: An International Journal of Medicine 2005;98:467-84. [DOI: 10.1093/qjmed/hci077] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 5.3] [Reference Citation Analysis]
123 San José G, Bidegain J, Robador PA, Díez J, Fortuño A, Zalba G. Insulin-induced NADPH oxidase activation promotes proliferation and matrix metalloproteinase activation in monocytes/macrophages. Free Radic Biol Med 2009;46:1058-67. [PMID: 19439231 DOI: 10.1016/j.freeradbiomed.2009.01.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
124 Almeda-valdés P, Cuevas-ramos D, Alberto Aguilar-salinas C. Metabolic syndrome and non-alcoholic fatty liver disease. Annals of Hepatology 2009;8:S18-24. [DOI: 10.1016/s1665-2681(19)31822-8] [Cited by in Crossref: 99] [Article Influence: 8.3] [Reference Citation Analysis]
125 Fallo F, Pozza AD, Sonino N, Federspil G, Ermani M, Baroselli S, Catena C, Soardo G, Carretta R, Belgrado D, Fabris B, Sechi LA. Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients. Journal of Hypertension 2008;26:2191-7. [DOI: 10.1097/hjh.0b013e32830dfe4b] [Cited by in Crossref: 30] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
126 Squillace N, Lapadula G, Torti C, Orlando G, Mandalia S, Nardini G, Beghetto B, Costarelli S, Guaraldi G. Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study. HIV Med 2008;9:151-9. [DOI: 10.1111/j.1468-1293.2007.00539.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
127 Hwu CM, Hsiao CF, Grove J, Hung YJ, Chuang LM, Chen YT, Curb JD, Chen YDI, Rodriguez B, Ho LT; the SAPPHIRe Study Group. Surrogate estimates of insulin sensitivity in subjects with hypertension. J Hum Hypertens 2007;21:246-52. [DOI: 10.1038/sj.jhh.1002137] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
128 Reaven G. The metabolic syndrome or the insulin resistance syndrome? Endocrinol Metab Clin North Am. 2004;33:283-303. [PMID: 15158520 DOI: 10.1016/j.ecl.2004.03.002] [Cited by in Crossref: 299] [Cited by in F6Publishing: 214] [Article Influence: 17.6] [Reference Citation Analysis]
129 Bremer AA, Stanhope KL, Graham JL, Cummings BP, Ampah SB, Saville BR, Havel PJ. Fish oil supplementation ameliorates fructose-induced hypertriglyceridemia and insulin resistance in adult male rhesus macaques. J Nutr 2014;144:5-11. [PMID: 24108131 DOI: 10.3945/jn.113.178061] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
130 Unek IT, Bayraktar F, Solmaz D, Ellidokuz H, Yuksel F, Sisman AR, Yesil S. Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome. Metabolism 2010;59:305-13. [DOI: 10.1016/j.metabol.2009.04.034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
131 Dalusung-Angosta A, Gutierrez A. Prevalence of metabolic syndrome among Filipino-Americans: a cross-sectional study. Appl Nurs Res 2013;26:192-7. [PMID: 23906437 DOI: 10.1016/j.apnr.2013.06.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
132 López-jaramillo P, Sánchez RA, Díaz M, Cobos L, Bryce A, Parra-carrillo JZ, Lizcano F, Lanas F, Sinay I, Sierra ID, Peñaherrera E, Benderky M, Schmid H, Botero R, Urina M, Lara J, Foos MC, Márquez G, Harrap S, Ramírez AJ, Zanchetti A. Consenso latinoamericano de hipertensión en pacientes con diabetes tipo 2 y síndrome metabólico. Clínica e Investigación en Arteriosclerosis 2014;26:85-103. [DOI: 10.1016/j.arteri.2013.11.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
133 Drimba L, Döbrönte R, Hegedüs C, Sári R, Di Y, Németh J, Szilvássy Z, Peitl B. The role of acute hyperinsulinemia in the development of cardiac arrhythmias. Naunyn Schmiedebergs Arch Pharmacol 2013;386:435-44. [PMID: 23474828 DOI: 10.1007/s00210-013-0845-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
134 El-Bassossy H, Badawy D, Neamatallah T, Fahmy A. Ferulic acid, a natural polyphenol, alleviates insulin resistance and hypertension in fructose fed rats: Effect on endothelial-dependent relaxation. Chem Biol Interact 2016;254:191-7. [PMID: 27287418 DOI: 10.1016/j.cbi.2016.06.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
135 Reaven GM. The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre? Journal of the American College of Nutrition 2007;26:191-5. [DOI: 10.1080/07315724.2007.10719601] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
136 Cavalieri L, Cremonesi G. Metabolic Effects of Manidipine. Am J Cardiovasc Drugs 2009;9:163-76. [DOI: 10.1007/bf03256573] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Akter S, Nanri A, Yi S, Pham NM, Kurotani K, Kimura Y, Matsushita Y, Mizoue T. Dietary patterns and C-peptide concentrations in a Japanese working population. Nutrition 2012;28:e29-35. [PMID: 22677358 DOI: 10.1016/j.nut.2012.01.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
138 Mishriky BM, Cummings DM, Tanenberg R, Pories WJ. Re-examining insulin compared to non-insulin therapies for type 2 diabetes: when in the disease trajectory is insulin preferable? Postgraduate Medicine 2018;130:653-9. [DOI: 10.1080/00325481.2018.1533381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]